missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30027739

ADAM8 Antibody (143338), FITC, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB10311F

Product Code. 30027739

  • £679.00 / 0.50mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ADAM8 Monoclonal antibody specifically detects ADAM8 in Human samples. It is validated for Western Blot, Immunoprecipitation, Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ADAM8
Monoclonal
FITC
PBS
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Western Blot, Immunoprecipitation, Flow Cytometry, CyTOF
143338
Western Blot, Immunoprecipitation, Intracellular Staining by Flow Cytometry, CyTOF-ready
a disintegrin and metalloproteinase domain 8, ADAM 8, ADAM metallopeptidase domain 8, CD156a antigen, CD156human leukocyte differentiation antigen, Cell surface antigen MS2, EC 3.4.24, EC 3.4.24.-, MGC134985, MS2disintegrin and metalloproteinase domain-containing protein 8
Mouse myeloma cell line NS0-derived recombinant human ADAM8 ectodomain, Asp158-Ser653, Accession # P78325
0.5 mL
Cellular Markers
101
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.